These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11504648)

  • 1. Synthesis and pharmacological activity of metabolites of the 5-HT(4) receptor antagonist SB-207266.
    Fedouloff M; Hossner F; Voyle M; Ranson J; Powles J; Riley G; Sanger G
    Bioorg Med Chem; 2001 Aug; 9(8):2119-28. PubMed ID: 11504648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-[(1-butyl-4-piperidinyl)methyl]-3,4dihydro-2H-[1,3]oxazino[3,2- a]indole10-carboxamide hydrochloride: the first potent and selective 5-HT4 receptor antagonist amide with oral activity.
    Gaster LM; Joiner GF; King FD; Wyman PA; Sutton JM; Bingham S; Ellis ES; Sanger GJ; Wardle KA
    J Med Chem; 1995 Nov; 38(24):4760-3. PubMed ID: 7490724
    [No Abstract]   [Full Text] [Related]  

  • 3. Tetrahydrobenzindoles: selective antagonists of the 5-HT7 receptor.
    Kikuchi C; Nagaso H; Hiranuma T; Koyama M
    J Med Chem; 1999 Feb; 42(4):533-5. PubMed ID: 10052959
    [No Abstract]   [Full Text] [Related]  

  • 4. 3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonists.
    Rowley M; Hallett DJ; Goodacre S; Moyes C; Crawforth J; Sparey TJ; Patel S; Marwood R; Patel S; Thomas S; Hitzel L; O'Connor D; Szeto N; Castro JL; Hutson PH; MacLeod AM
    J Med Chem; 2001 May; 44(10):1603-14. PubMed ID: 11334570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective, centrally acting serotonin 5-HT2 antagonists. 2. Substituted 3-(4-fluorophenyl)-1H-indoles.
    Andersen K; Perregaard J; Arnt J; Nielsen JB; Begtrup M
    J Med Chem; 1992 Dec; 35(26):4823-31. PubMed ID: 1336054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azabicyclic indole esters as potent 5-HT4 receptor antagonists.
    Wyman PA; Gaster LM; King FD; Sutton JM; Ellis ES; Wardle KA; Young TJ
    Bioorg Med Chem; 1996 Feb; 4(2):255-61. PubMed ID: 8814883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High affinity of SDZ HTF-919 related molecules for calf and human caudate 5-HT4 receptors.
    Hoyer D; Fehlmann D; Langenegger D; Kummer J; Giger R; Mattes H; Probst A; Pfannkuche HJ
    Ann N Y Acad Sci; 1998 Dec; 861():267-8. PubMed ID: 9928283
    [No Abstract]   [Full Text] [Related]  

  • 9. (1-Butyl-4-piperidinyl)methyl 8-amino-7-chloro-1,4-benzodioxane-5-carboxylate hydrochloride: a highly potent and selective 5-HT4 receptor antagonist derived from metoclopramide.
    Gaster LM; Jennings AJ; Joiner GF; King FD; Mulholland KR; Rahman SK; Starr S; Wyman PA; Wardle KA; Ellis ES
    J Med Chem; 1993 Dec; 36(25):4121-3. PubMed ID: 8258837
    [No Abstract]   [Full Text] [Related]  

  • 10. [3H]5-hydroxytryptamine labels the agonist high affinity state of the cloned rat 5-HT4 receptor.
    Adham N; Gerald C; Schechter L; Vaysse P; Weinshank R; Branchek T
    Eur J Pharmacol; 1996 May; 304(1-3):231-5. PubMed ID: 8813606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and serotonergic activity of substituted 2, N-benzylcarboxamido-5-(2-ethyl-1-dioxoimidazolidinyl)-N, N-dimethyltryptamine derivatives: novel antagonists for the vascular 5-HT(1B)-like receptor.
    Moloney GP; Martin GR; Mathews N; Milne A; Hobbs H; Dodsworth S; Sang PY; Knight C; Williams M; Maxwell M; Glen RC
    J Med Chem; 1999 Jul; 42(14):2504-26. PubMed ID: 10411472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of the 5-HT(4) receptor in the human and the guinea pig colon.
    Sakurai-Yamashita Y; Yamashita K; Kanematsu T; Taniyama K
    Eur J Pharmacol; 1999 Nov; 383(3):281-5. PubMed ID: 10594320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo.
    Gaster LM; Blaney FE; Davies S; Duckworth DM; Ham P; Jenkins S; Jennings AJ; Joiner GF; King FD; Mulholland KR; Wyman PA; Hagan JJ; Hatcher J; Jones BJ; Middlemiss DN; Price GW; Riley G; Roberts C; Routledge C; Selkirk J; Slade PD
    J Med Chem; 1998 Apr; 41(8):1218-35. PubMed ID: 9548813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective, centrally acting serotonin 5-HT2 antagonists. 1. 2- and 6-substituted 1-phenyl-3-(4-piperidinyl)-1H-indoles.
    Perregaard J; Andersen K; Hyttel J; Sánchez C
    J Med Chem; 1992 Dec; 35(26):4813-22. PubMed ID: 1336053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-Bicyclopiperazinyl-1-arylsulfonylindoles and 6-bicyclopiperidinyl-1-arylsulfonylindoles derivatives as novel, potent, and selective 5-HT6 receptor antagonists.
    Isaac M; Slassi A; Xin T; MacLean N; Wilson J; McCallum K; Wang H; Demchyshyn L
    Bioorg Med Chem Lett; 2000 Aug; 10(15):1719-21. PubMed ID: 10937732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a potent and selective 5-ht5A receptor antagonist by high-throughput chemistry.
    Corbett DF; Heightman TD; Moss SF; Bromidge SM; Coggon SA; Longley MJ; Roa AM; Williams JA; Thomas DR
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4014-8. PubMed ID: 16002289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.
    Medina RA; Sallander J; Benhamú B; Porras E; Campillo M; Pardo L; López-Rodríguez ML
    J Med Chem; 2009 Apr; 52(8):2384-92. PubMed ID: 19326916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer's disease.
    Yahiaoui S; Hamidouche K; Ballandonne C; Davis A; de Oliveira Santos JS; Freret T; Boulouard M; Rochais C; Dallemagne P
    Eur J Med Chem; 2016 Oct; 121():283-293. PubMed ID: 27266998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studies.
    Sagnes C; Fournet G; Satala G; Bojarski AJ; Joseph B
    Eur J Med Chem; 2014 Mar; 75():159-68. PubMed ID: 24531229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 5-HT4 receptors in guinea-pig colon and rat oesophagus: effects of novel agonists and antagonists.
    Leung E; Pulido-Rios MT; Bonhaus DW; Pekins LA; Zeitung KD; Hsu SA; Clark RD; Wong EH; Eglen RM
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):145-56. PubMed ID: 8857591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.